Author: Ahmed Younes, M.D.

Administration of Cangrelor In Addition to Crushed Ticagrelor Bridges Gap of Antiplatelet Inhibition in Patients Undergoing Primary PCI
Acute Coronary Syndrome, Coronary Artery Disease, Interventional Cardiology

Administration of Cangrelor In Addition to Crushed Ticagrelor Bridges Gap of Antiplatelet Inhibition in Patients Undergoing Primary PCI

According to a new study, Cangrelor could serve to bridge the gap of antiplatelet inhibition in patients undergoing primary percutaneous coronary intervention (P-PCI)... Read more.
2018: Cardiology News at A Glance
Acute Coronary Syndrome, Arrhythmia and Electrophysiology, Cardiogenic shock, Cardiovascular Imaging, Cardiovascular Prevention, Cardiovascular Surgery, Clinical Trials, Conferences, Coronary Artery Disease, Heart Failure, Hypertension, News, Prevention, Uncategorized

2018: Cardiology News at A Glance

COAPT trial This prospective, multicenter, open-label, randomized trial aimed to assess the use of transcatheter mitral valve repair in heart failure (HF) patients... Read more.
Coronary Artery Calcium Scoring: A Screening Tool For Statin Prescription In the Primary Prevention of Cardiovascular Disease?
Cerebrovascular Disease, Coronary Artery Disease, Lipid Lowering Therapy

Coronary Artery Calcium Scoring: A Screening Tool For Statin Prescription In the Primary Prevention of Cardiovascular Disease?

According to a new study published in the Journal of American College of Cardiology, patients with higher coronary artery calcium (CAC) scores were more likely to... Read more.
Canakinumab: A New Hope for Post MI Patients with Increased hsCRP in the Prevention of Heart Failure
Acute Coronary Syndrome, Cardiovascular Prevention, Coronary Artery Disease, Heart Failure, News

Canakinumab: A New Hope for Post MI Patients with Increased hsCRP in the Prevention of Heart Failure

Canakinumab (an IL-B inhibitor) is associated with decreased heart failure (HF) hospitalizations and the composite of heart failure hospitalization and heart-failure... Read more.
Persistently High Residual Inflammatory Risk Associated with Increased Mortality and MI Risk in Patients Undergoing PCI
Acute Coronary Syndrome, Cerebrovascular Disease, Coronary Artery Disease

Persistently High Residual Inflammatory Risk Associated with Increased Mortality and MI Risk in Patients Undergoing PCI

A recent study published in the European Heart Journal showed that a high percentage of patients undergoing percutaneous coronary intervention (PCI) had persistently... Read more.